Grantham, Mayo, Van Otterloo & Co (GMO)’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,100
Closed -$261K 703
2019
Q1
$261K Hold
10,100
﹤0.01% 655
2018
Q4
$247K Sell
10,100
-15,800
-61% -$429K ﹤0.01% 495
2018
Q3
$748K Sell
25,900
-2,900
-10% -$82.4K 0.01% 405
2018
Q2
$749K Sell
28,800
-16,300
-36% -$421K 0.01% 410
2018
Q1
$1.31M Buy
45,100
+23,800
+112% +$693K 0.01% 355
2017
Q4
$559K Buy
+21,300
New +$608K ﹤0.01% 448

Other funds holding BAK

Grantham, Mayo, Van Otterloo & Co (GMO)'s BAK Position: Q2 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Braskem (BAK) in Q2 2019, closing a stake of 10,100 shares — an estimated $261K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BAK in Q4 2017 and held it in 6 quarters. The position peaked at $1.31M in Q1 2018. 17 funds tracked by Wall St. Rank hold BAK as of Q2 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Braskem position as of Q2 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,100 Braskem shares in Q2 2019, an estimated $261K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Braskem in Q4 2017 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Braskem position peaked at $1.31M in Q1 2018.
  • 17 funds tracked by Wall St. Rank held Braskem as of Q2 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2019, filed 13 Aug 2019.